Key facts
- Coral’s last known valuation is $6.9M (Feb 2025).
- It has raised $5.8M; the latest was Early Stage VC ($2.9M) in Mar 2026.
- Notable investors include Flybridge (New York), Diagram Ventures, AQC Capital, Anges Québec, Brightspark Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Coral
- ·The full record, as it builds
Funding rounds
No funding rounds for Coral are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coral
Operator of a women's digital health platform intended to improve the lives of women through specialized care for perimenopause and menopause. The company's platform provides evidence-based treatments, personalized support, ongoing care, and research-backed services such as nutrition, mental health, lifestyle support, and pharmaceutical interventions, enabling women to take control of their health during midlife and beyond while empowering them to thrive through comprehensive symptom relief and prevention practices.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2024
- Website
- coral.ca/
- Ownership
- Privately Held (backing)
Coral doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coral shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coral in its N-PORT filings yet. We sweep new filings monthly.